Skip to main content

The Hemodynamically Labile Patient: Cardiovascular Adjuncts and Assist Devices

  • Chapter
Book cover Acute Care Surgery

Abstract

A 66-year-old retired teacher is being managed in the intensive care unit after having a myocardial infarction. The patient had no prior medical problems. The patient is hemodynamically labile and is refractory to volume support and all pharmacologic interventions. The patient is now in profound cardiogenic shock. Which of the following would most likely be the management of choice?

  1. (A)

    Emergency cardiac catheterization

  2. (B)

    Coronary artery bypass surgery

  3. (C)

    Intraaortic balloon pump

  4. (D)

    Continue inotropic support

  5. (E)

    No further intervention is needed

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chernow B, Rothl BL. Pharmacological manipulation of the peripheral vasculature in shock: clinical and experimental approaches. Circ Shock 1986; 18:141–155.

    CAS  PubMed  Google Scholar 

  2. Landry DW, Levin HR, Gallant EM, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997; 25(8):1279–1282.

    Article  CAS  PubMed  Google Scholar 

  3. Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95:1122–1125.

    CAS  PubMed  Google Scholar 

  4. Reid IA. Role of vasopressin deficiency in the vasodilation of septic shock. Circulation, 1997; 95:1108–1110.

    CAS  PubMed  Google Scholar 

  5. Dunser MW, Mayr AJ, Ulmer H, et al. Arginine vasopressin in advanced shock: a prospective, randomized, controlled study. Circulation 2003; 107(18):2313–1319.

    Article  PubMed  CAS  Google Scholar 

  6. Patel BM, Chittock DR, Russell JA, et al. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96(3):576–582.

    Article  CAS  PubMed  Google Scholar 

  7. Malay MB, Ashton RC Jr, Landry DW, et al. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999; 47(4):699–703.

    Article  CAS  PubMed  Google Scholar 

  8. Argenziano M, Choudhri AF, Oz MC, et al. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation 1997; 96(Suppl II):II-286–II-290.

    Google Scholar 

  9. Hill D, O’Brien TG, Murray JJ, et al. Extracorporeal oxygenation for acute post-traumatic respiratory failure (shock lung syndrome). Use of the Bramson membrane lung. N Engl J Med 1972; 286:629–634.

    Article  CAS  PubMed  Google Scholar 

  10. Doll N, Kiaii B, Borger M, et al. Five year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg 2004; 77:151–157.

    Article  PubMed  Google Scholar 

  11. Schwarz B, Mair P, Margreikter J, et al. Experience with percutaneous venoarterial cardiopulmonary bypass for emergency circulatory support. Crit Care Med 2003; 31(3): 758–764.

    Article  PubMed  Google Scholar 

  12. Ko WJ, Lin CY, Chen RJ, et al. Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. Ann Thorac Surg 2002; 73(2):538–545.

    Article  PubMed  Google Scholar 

  13. Kantrowitz A, Tjonneland S, Freed PS, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA 1968; 203:113–118.

    Article  CAS  PubMed  Google Scholar 

  14. Baskett RJF, O’Connor GT, Hirsch GM, et al. A multicenter comparison of intraaortic balloon pump utilization in isolated coronary artery bypass graft surgery. Ann Thorac Surg 2003; 76:1988–1992.

    Article  PubMed  Google Scholar 

  15. Stone GW, Magnus Ohman E, Miller MF, et al. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction. J Am Coll Cardiol 2003; 41:1940–1950.

    Article  PubMed  Google Scholar 

  16. Christenson JT, Simonet F, Badel P, et al. Optimal timing of preoperative intra-aortic balloon pump support in highrisk coronary patients. Ann Thorac Surg 1999; 68:934–939.

    Article  CAS  PubMed  Google Scholar 

  17. Christenson JT, Badel P, Simonet F, et al. Preoperative intraaortic balloon pump enhances cardiac performance and improves the outcome of redo CABG. Ann Thorac Surg 1997; 64:1237–1244.

    Article  CAS  PubMed  Google Scholar 

  18. Christenson JT, Simonet F, Badel P, et al. Evaluation of preoperative intra-aortic balloon pump support in high risk coronary patients. Eur J Cardiothorac Surg 1997; 11(6): 1097–1103

    Article  CAS  PubMed  Google Scholar 

  19. Ohman EM, George BS, White CJ, et al. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The randomized IABP study group. Circulation 1994; 90(2):792–799.

    CAS  PubMed  Google Scholar 

  20. Madigan JD, et al. Time course of reverse modeling of the left ventricle during support with a left ventricular assist device. J Thorac Cardiovasc Surg 2001; 121(5):902–908.

    Article  CAS  PubMed  Google Scholar 

  21. Mehta SM, et al. Mechanical ventricular assistance: an economical and effective means of treating end-stage heart disease. Ann Thorac Surg 1995; 60(2):284–290.

    Article  CAS  PubMed  Google Scholar 

  22. Aaronson KD, et al. Left ventricular assist device therapy improves utilization of donor hearts. J Am Coll Cardiol 2002; 39(8):1247–1254.

    Article  PubMed  Google Scholar 

  23. Frazier OH, Reynolds M, Delgado M. Mechanical circulatory support for advanced heart failure. Where does it stand in 2003? Circulation 2003; 108:3064–3068.

    Article  CAS  PubMed  Google Scholar 

  24. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med 1998; 339(21):1522–1533.

    Article  CAS  PubMed  Google Scholar 

  25. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical ventricular assistance for end-stage heart failure. N Engl J Med 2001; 15(20):1435–1443.

    Article  Google Scholar 

  26. Rose EA, Moskowitz AJ, Packer M, et al. The REMATCH trial: rationale, design, and end points. Ann Thorac Surg 1999; 67:723–730.

    Article  CAS  PubMed  Google Scholar 

  27. Richenbacher WE, Naka Y, Raines NY, et al. Surgical management of patients in the REMATCH trial. Ann Thorac Surg 2003; 75(Suppl):S86–S92.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Cornwell, E.E., John, P.R. (2007). The Hemodynamically Labile Patient: Cardiovascular Adjuncts and Assist Devices. In: Britt, L.D., Trunkey, D.D., Feliciano, D.V. (eds) Acute Care Surgery. Springer, New York, NY. https://doi.org/10.1007/978-0-387-69012-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-69012-4_6

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-34470-6

  • Online ISBN: 978-0-387-69012-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics